To determine whether CD3- IL7R+ cells present in diseased mucosa of IBD patients were responsive to IL6, cLPMCs were incubated overnight with recombinant human IL6 before being restimulated with PMA and ionomycin. The gene discussed is IL7R; the disease is inflammatory bowel disease.